SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines

被引：0
|
作者：
Giovanni Salvatori
Laura Luberto
Mariano Maffei
Luigi Aurisicchio
Giuseppe Roscilli
Fabio Palombo
Emanuele Marra
机构：
[1] Takis s.r.l,
[2] Evvivax s.r.l,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
SARS-CoV-2; SPIKE protein; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
COVID-19 has rapidly spread all over the world, progressing into a pandemic. This situation has urgently impelled many companies and public research institutes to concentrate their efforts on research for effective therapeutics. Here, we outline the strategies and targets currently adopted in developing a vaccine against SARS-CoV-2. Based on previous evidence and experience with SARS and MERS, the primary focus has been the Spike protein, considered as the ideal target for COVID-19 immunotherapies.
引用
收藏
相关论文
共 50 条
  • [1] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
    Salvatori, Giovanni
    Luberto, Laura
    Maffei, Mariano
    Aurisicchio, Luigi
    Roscilli, Giuseppe
    Palombo, Fabio
    Marra, Emanuele
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [2] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
    Ahmed M. Almehdi
    Ghalia Khoder
    Aminah S. Alchakee
    Azizeh T. Alsayyid
    Nadin H. Sarg
    Sameh S. M. Soliman
    [J]. Infection, 2021, 49 : 855 - 876
  • [3] SARS-CoV-2 variants- Evolution, spike protein, and vaccines
    Chen, Kai-Wei K.
    Huang, Daniel Tsung-Ning
    Huang, Li -Min
    [J]. BIOMEDICAL JOURNAL, 2022, 45 (04) : 573 - 579
  • [4] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
    Almehdi, Ahmed M.
    Khoder, Ghalia
    Alchakee, Aminah S.
    Alsayyid, Azizeh T.
    Sarg, Nadin H.
    Soliman, Sameh S. M.
    [J]. INFECTION, 2021, 49 (05) : 855 - 876
  • [5] Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
    Lim, Heeji
    Kim, Se Eun
    Lee, Yun Ha
    Hwang, Yun-Ho
    Kim, Su Hwan
    Kim, Mi Young
    Chung, Gyung Tae
    Kim, You-Jin
    Kim, Dokeun
    Lee, Jung-Ah
    [J]. VIROLOGY, 2022, 573 : 118 - 123
  • [6] Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
    Sundaram, Appavu K.
    Ewing, Daniel
    Liang, Zhaodong
    Jani, Vihasi
    Cheng, Ying
    Sun, Peifang
    Raviprakash, Kanakatte
    Wu, Shuenn-Jue
    Petrovsky, Nikolai
    Defang, Gabriel
    Williams, Maya
    Porter, Kevin R.
    [J]. PATHOGENS, 2021, 10 (05):
  • [7] SARS-CoV-2 and the spike protein in endotheliopathy
    Perico, Luca
    Benigni, Ariela
    Remuzzi, Giuseppe
    [J]. TRENDS IN MICROBIOLOGY, 2024, 32 (01) : 53 - 67
  • [8] Structure of SARS-CoV-2 spike protein
    Zhang, Jun
    Xiao, Tianshu
    Cai, Yongfei
    Chen, Bing
    [J]. CURRENT OPINION IN VIROLOGY, 2021, 50 : 173 - 182
  • [9] Amyloidogenesis of SARS-CoV-2 Spike Protein
    Nystrom, Sofie
    Hammarstrom, Per
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (20) : 8945 - 8950
  • [10] SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
    Pierri, Ciro Leonardo
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
12345